ArticlePharmaceuticals (Basel, Switzerland)2023

Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway.

Fenglin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.